TrialCirculation2022

Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.

Gerasimos Filippatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.